Send us Feedback

Peregrine Pharmaceuticals (PPHM)
Analysis
Data
Financials
No Sales Breakout Data.
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 31-JUL
2008		 31-OCT
2008		 31-JAN
2009		 30-APR
2009		 31-JUL
2009		 newer
Cash & Equivalents 9.96M 8.21M 10.8M 10.0M 12.8M
Short Term Investments 0 0 0 0 0
Accounts Receivable 3.89M 2.58M 2.35M 3.71M 3.16M
Inventories 4.63M 6.70M 5.55M 4.71M 6.18M
Pre-paid Expenses 1.20M 1.14M 685K 1.47M 991K
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 0 0 248K 229K 202K
Total Current Assets 19.7M 18.6M 19.7M 20.1M 23.3M
Property, Plant & Equipment 1.93M 1.91M 1.80M 1.68M 1.57M
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 1.20M 1.20M 1.34M 1.31M 1.33M
Total Long-Term Assets 3.13M 3.11M 3.14M 2.99M 2.90M
Total Assets 22.8M 21.7M 22.8M 23.1M 26.2M
Accounts Payable 3.13M 3.42M 2.89M 3.52M 3.40M
Accrued Expenses 0 0 0 0 0
Short Term Debt 22K 23K 969K 1.48M 1.82M
Other Current Liabilities 7.24M 10.1M 9.23M 10.5M 9.68M
Total Current Liabilities 12.0M 15.2M 15.2M 18.9M 18.1M
Long Term Debt 0 0 3.67M 3.21M 2.74M
Capital Lease Obligations 16K 10K 6K 4K 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 0 0 150K 150K 153K
Total Long-term Liabilities 16K 10K 3.82M 3.36M 2.90M
Minority Interest 0 0 0 0 0
Total Liabilities 12.0M 15.2M 19.0M 22.2M 21.0M
Preferred Stock 0 0 0 0 0
Common Par 226K 226K 226K 227K 237K
Additional Paid-In Capital 246M 247M 247M 248M 255M
Retained Earnings -236M -240M -244M -247M -250M
Treasury Stock 0 0 0 0 0
Other Equity 0 0 0 0 0
Total Shareholder's Equity 10.8M 6.50M 3.79M 901K 5.22M
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki